The refinancing package extends the maturity of Symplr's first-lien term loan and revolving credit facility to December 2030, while pushing second-lien term loans to June 2031. By injecting fresh capital and easing near-term cash interest requirements, the company gains significant flexibility to continue scaling its enterprise operations platform. CEO Venkat Kavarthapu described the support from existing lenders and sponsors as a clear validation of the firm’s current trajectory and its role in the U.S. healthcare market. With the transaction expected to close by the end of October, Symplr remains committed to its core focus of optimizing workforce, quality, and provider data management across its network of 400 health plans and nine out of ten U.S. hospitals.